PATRICIA GOODMAN: Open Payments
NPI 1376017236 · UPPR MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,265 in 151 payments from 19 companies in 2025. Trend: 2023 $2,017 · 2024 $2,371 · 2025 $3,265
Food & beverage: $3,220Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $593 |
| Janssen Biotech, Inc. | 16 | $497 |
| ANI Pharmaceuticals, Inc. | 28 | $380 |
| Novartis Pharmaceuticals Corporation | 13 | $337 |
| Amgen Inc. | 14 | $316 |
| AstraZeneca Pharmaceuticals LP | 10 | $251 |
| UCB, Inc. | 14 | $245 |
| Aurinia Pharma U.S., Inc. | 10 | $170 |
| Janssen Pharmaceuticals, Inc | 5 | $116 |
| GlaxoSmithKline, LLC. | 5 | $112 |
Products named: TREMFYA, SKYRIZI, SOVUNA, Bimzelx, ILARIS, RINVOQ, SAPHNELO, LUPKYNIS.
Industry payments across MD — which companies pay providers there.
